Elanco Animal Health Files 8-K on Operations and Exit Costs
Ticker: ELAN · Form: 8-K · Filed: Feb 26, 2024 · CIK: 1739104
| Field | Detail |
|---|---|
| Company | Elanco Animal Health Inc (ELAN) |
| Form Type | 8-K |
| Filed Date | Feb 26, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $50, $55 million, $40, $45 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, operational-update, restructuring
TL;DR
**Elanco just dropped an 8-K detailing their latest financial results and some exit costs, so keep an eye on their operational efficiency!**
AI Summary
Elanco Animal Health Inc. filed an 8-K on February 22, 2024, reporting on its results of operations and financial condition, as well as costs associated with exit or disposal activities. The filing indicates the company's current financial status and any significant restructuring costs incurred.
Why It Matters
This filing provides investors with crucial insights into Elanco's recent financial performance and any strategic changes involving asset disposals or operational exits, which can impact future profitability.
Risk Assessment
Risk Level: medium — The filing is an informational update without immediate indication of significant positive or negative financial events.
Key Players & Entities
- Elanco Animal Health Inc. (company) — Registrant
- February 22, 2024 (date) — Date of earliest event reported
- 001-38661 (other) — Commission File Number
- 82-5497352 (other) — I.R.S. Employer Identification No.
FAQ
What was the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing was February 22, 2024.
What items of information were included in this 8-K filing?
The 8-K filing included information on Results of Operations and Financial Condition, Cost Associated with Exit or Disposal Activities, and Financial Statements and Exhibits.
What is the Registrant's telephone number?
The Registrant's telephone number is (877) 352-6261.
What is the Commission File Number for Elanco Animal Health Inc.?
The Commission File Number for Elanco Animal Health Inc. is 001-38661.
Where is Elanco Animal Health Inc.'s principal executive office located?
Elanco Animal Health Inc.'s principal executive office is located at 2500 INNOVATION WAY, GREENFIELD, INDIANA, 46140.
Filing Stats: 637 words · 3 min read · ~2 pages · Grade level 11.9 · Accepted 2024-02-26 06:30:15
Key Financial Figures
- $50 — iated with the restructuring plan total $50 to $55 million in 2024, including $40 t
- $55 million — ith the restructuring plan total $50 to $55 million in 2024, including $40 to $45 million o
- $40 — l $50 to $55 million in 2024, including $40 to $45 million of cash-based severance
- $45 million — o $55 million in 2024, including $40 to $45 million of cash-based severance costs, a majori
Filing Documents
- elan-20240222.htm (8-K) — 29KB
- elanco-12312023exhibit991.htm (EX-99.1) — 406KB
- image1a.jpg (GRAPHIC) — 209KB
- 0001739104-24-000004.txt ( ) — 850KB
- elan-20240222.xsd (EX-101.SCH) — 2KB
- elan-20240222_lab.xml (EX-101.LAB) — 23KB
- elan-20240222_pre.xml (EX-101.PRE) — 12KB
- elan-20240222_htm.xml (XML) — 3KB
02 Results of Operations or Financial Condition
Item 2.02 Results of Operations or Financial Condition. Attached as Exhibit 99.1 and incorporated by reference into this Item 2.02 is a copy of the press release, dated February 26, 2024, announcing the results of operations for the full year and fiscal quarter ended December 31, 2023, and guidance for the full year and first quarter of 2024, for Elanco Animal Health Incorporated. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended ("Exchange Act"), or otherwise subject to the liabilities of that Section and shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such filing.
05 Costs Associated with Exit or Disposal Activities
Item 2.05 Costs Associated with Exit or Disposal Activities. On February 22, 2024, the Board of Directors of Elanco Animal Health Incorporated authorized a restructuring plan with respect to its workforce (the "Restructuring Plan") to improve operational efficiencies and better align the Company's organizational structure with current business needs, top strategic priorities and key growth opportunities. The restructuring plan will result in the elimination of approximately 420 personnel across our global organization. Expected pre-tax charges associated with the restructuring plan total $50 to $55 million in 2024, including $40 to $45 million of cash-based severance costs, a majority of which will be paid in 2024.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release issued by Elanco Animal Health Incorporated dated February 26 , 202 4 104.1 Cover Page Interactive Data File (embedded within the Inline XBRL document)
Signatures
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ELANCO ANIMAL HEALTH INCORPORATED Date: February 26, 2024 /s/ Todd S. Young Todd S. Young Executive Vice President and Chief Financial Officer